FDA
Imatinib Mesylate
The FDA lists this product in 32 strengths and forms.
Composition
- Active ingredients
- IMATINIB MESYLATE EQ 100MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- IMATINIB MESYLATE EQ 100MG BASE · TabletANDA207818-001 · Prescription
- IMATINIB MESYLATE EQ 400MG BASE · TabletANDA207818-002 · Prescription
- IMATINIB MESYLATE EQ 400MG BASE · TabletANDA212773-002 · Prescription
- IMATINIB MESYLATE EQ 100MG BASE · TabletANDA212773-001 · Prescription
- IMATINIB MESYLATE EQ 400MG BASE · TabletANDA212975-002 · Prescription
- IMATINIB MESYLATE EQ 100MG BASE · TabletANDA212975-001 · Prescription
- IMATINIB MESYLATE EQ 400MG BASE · TabletANDA212135-002 · Prescription
- IMATINIB MESYLATE EQ 100MG BASE · TabletANDA212135-001 · Prescription
- IMATINIB MESYLATE EQ 400MG BASE · TabletANDA079179-002 · Prescription
- IMATINIB MESYLATE EQ 100MG BASE · TabletANDA079179-001 · Prescription
- IMATINIB MESYLATE EQ 400MG BASE · TabletANDA206547-002 · Prescription
- IMATINIB MESYLATE EQ 100MG BASE · Tablet
At a glance
- Brand name
- Imatinib Mesylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hikma
- Status
- Discontinued
- FDA approval
- 13 Jul 2018
- Application
- ANDA207586-001